Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.
Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV, Quinlan E, Zimmer-Galler I, Haller JA, Solomon SD, Sung JU, Hadi Y, Janjua KA, Jawed N, Choy DF, Arron JR. Campochiaro PA, et al. Among authors: janjua ka. Mol Ther. 2008 Apr;16(4):791-9. doi: 10.1038/mt.2008.10. Epub 2008 Feb 5. Mol Ther. 2008. PMID: 18362932 Free article. Clinical Trial.
Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial.
Guerra-Farfan E, Borges FK, Bhandari M, Garcia-Sanchez Y, Nuñez JH, Mestre-Torres J, Tomas-Hernandez J, Teixidor-Serra J, Balaguer-Castro M, Castillon P, Dealbert A, De Caso Rodriguez J, Aguado HJ, Guerado E, Popova E, Tonelli AC, Balasubramanian K, Vincent J, Harvey V, Kocaqi E, Slobogean G, Devereaux PJ; Hip Attack-1 Investigators. Guerra-Farfan E, et al. Injury. 2024 Nov;55(11):111827. doi: 10.1016/j.injury.2024.111827. Epub 2024 Aug 20. Injury. 2024. PMID: 39217648 Clinical Trial.
Accelerated Surgery Versus Standard Care in Hip Fracture (HIP ATTACK-1): A Kidney Substudy of a Randomized Clinical Trial.
Borges FK, Devereaux PJ, Cuerden M, Sontrop JM, Bhandari M, Guerra-Farfán E, Patel A, Sigamani A, Umer M, Neary J, Tiboni M, Tandon V, Ramokgopa MT, Sancheti P, Lawendy AR, Balaguer-Castro M, Jenkinson R, Ślęczka P, Nur AN, Wood GCA, Feibel RJ, McMahon JS, Biccard BM, Ortalda A, Szczeklik W, Wang CY, Tomás-Hernández J, Vincent J, Harvey V, Pettit S, Balasubramanian K, Slobogean G, Garg AX; HIP ATTACK-1 Investigators. Borges FK, et al. Am J Kidney Dis. 2022 Nov;80(5):686-689. doi: 10.1053/j.ajkd.2022.01.431. Epub 2022 Mar 26. Am J Kidney Dis. 2022. PMID: 35346742 Clinical Trial. No abstract available.
Nanocurcumin: A Double-Edged Sword for Microcancers.
Janjua KA, Shehzad A, Shahzad R, Islam SU, Islam MU. Janjua KA, et al. Curr Pharm Des. 2020;26(45):5783-5792. doi: 10.2174/1381612826666201118100045. Curr Pharm Des. 2020. PMID: 33213321 Review.
12 results